Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
Vaccines|October 26, 2021
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP InhibitorsMichalis Liontos, Evangelos Terpos, Christos Markellos, et al.
Prostate Cancer and Prostatic Diseases|October 10, 2021
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patientsMichalis Liontos, Evangelos Terpos, Elena Kunadis, et al.
Plos One|June 4, 2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic ProfilingSofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, et al.
Epilepsia|April 20, 2022
A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndromePasquale Striano, Stéphane Auvin, Abigail Collins, et al.
Communications Medicine|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamstersCatherine Berry, Vincent Pavot, Natalie G Anosova, et al.
Vaccine|January 15, 2020
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01<sub>B</sub> vaccinationOlivier Van Der Meeren, Erik Jongert, Kelly E Seaton, et al.
Clinical Genitourinary Cancer|October 7, 2015
Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)Aristotle Bamias, Stavros Peroukidis, Sophia Stamatopoulou, et al.
Cancer Management and Research|August 6, 2021
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and OutcomesAthanasios Dellis, Roubini Zakopoulou, Andromahi Kougioumtzopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumorsLee S Rosen, Razelle Kurzrock, Marilyn Mulay, et al.
Pageof 24